Reduced Klotho is associated with the presence and severity of coronary artery disease.
about
Klotho in cardiovascular disease: Current and future perspectivesSignificant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular diseaseFrom "Kidneys Govern Bones" to Chronic Kidney Disease, Diabetes Mellitus, and Metabolic Bone Disorder: A Crosstalk between Traditional Chinese Medicine and Modern ScienceCardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicabilityPolymorphism of klotho G-395A and susceptibility of coronary artery disease in East-Asia population: a meta-analysisFGF23 and vascular calcifications: another piece of the puzzle?Klotho ameliorates oxidized low density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathwaysαKlotho and vascular calcification: an evolving paradigm.Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.Implications of Klotho in vascular health and disease.Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patientsAssociation between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease StagesKlotho-related Molecules Upregulated by Smoking Habit in Apparently Healthy Men: A Cross-sectional Study.α-Klotho Expression in Human Tissues.Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease.Soluble Klotho protein as a novel serum biomarker in patients with acromegaly.Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients.Is Klotho deficiency independently associated with cardiovascular risk in chronic kidney disease?Phosphate Toxicity in CKD: The Killer among UsConcentrations of fetuin-A, osteoprotegerin and α-Klotho in patients with alcoholic liver cirrhosis.Vitamin D: a new player in kidney transplantation?Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.Decreased expression of Klotho in cardiac atria biopsy samples from patients at higher risk of atherosclerotic cardiovascular diseaseKlotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells.αKlotho and Chronic Kidney Disease.Is Low Serum Klotho Level Associated with Alterations in Coronary Flow Reserve?Relationship between abdominal aortic and coronary artery calcification as detected by computed tomography in chronic kidney disease patients.Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.Glucose Oxidase Induces Cellular Senescence in Immortal Renal Cells through ILK by Downregulating Klotho Gene Expression.Cardiovascular risks in chronic kidney disease pediatric patients.The effects of aerobic and anaerobic exercises on circulating soluble-Klotho and IGF-I in young and elderly adults and in CAD patients.Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue.Is there a role for newer biomarkers in chronic kidney disease-mineral and bone disorder management?Relationship between left main and left anterior descending arteries bifurcation angle and coronary artery calcium score in chronic kidney disease: A 3-dimensional analysis of coronary computed tomography.Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability
P2860
Q26775409-B3F287C6-EEC5-4030-8844-281978AA714BQ26782946-EF057343-3335-4574-B015-1A3A26C56E00Q28079011-B0FE6F6F-0E80-470F-9DA0-7DCCCF143BB6Q28081407-751B4C55-1449-4584-B77E-AAA43E441F0DQ28087392-E41FD50E-4D1E-4A72-9493-677F95648850Q33358225-A0E30727-887A-424E-9DEC-E45DD7E12571Q33560682-B13CE85C-E452-43F4-BEAA-08785AE7E4ADQ34078872-4362C511-01DE-47D4-BE0C-8E81E34A3796Q34204949-FE180D86-6BDD-4D21-A26E-54729F778E4EQ34780123-39EC443A-17C3-487E-8A30-98B8105C0DC1Q34941418-C0B7B06A-FE41-4BD2-BA55-4B3E9214C7A3Q36072709-AB24D0A5-672F-4FB1-B40C-04C5920F857CQ36098882-2272BE22-E7A8-43D8-A424-167BEE6699FFQ36129776-F47FE508-2F27-4AB0-B8A0-992D730B6AEFQ36476878-ED4FF41B-E495-4451-9226-F5CBCCDF1AACQ36582313-98C01180-4EF2-448E-888B-9B2DF09B8DBBQ36740444-C9A4BBAD-C5F8-4557-BAD2-AAD398CBC2DAQ36740455-A5CE3250-BAEB-4DF8-8DD6-502808F2D83DQ36965142-98F36AE4-4514-4E47-B1FE-0565F0941053Q37406696-CA68DD44-AC60-49A1-9E10-DE396DB1BE74Q38241062-65B4AE5C-F3A9-4900-BAF4-E4A85159693BQ39009566-56A81D89-A1BF-4756-ADE3-E7D1B29BBD7CQ39249797-38993B98-15F6-4D5A-B94A-43319F1F303FQ39569165-B688AABC-0C82-416F-BED8-5E491B23A065Q39812781-5063740F-C7F6-4435-A4BC-4C1BF67A52E0Q40082186-839871EF-258D-4BBB-8A8B-CF9A2F9EBBBCQ40747969-400E69C5-BBEE-43A9-8E69-4A8EFD2F34FAQ41611152-C3FC4EC0-E0D8-4E9F-BFBA-95ACE48498DEQ42246015-5A4E645A-CA7F-437F-8E1B-CB3229855E5EQ47112805-FB819664-D72D-4567-B54B-AE02E10F91B3Q51787996-24E80478-C34A-4C9C-8CEA-CAF412F5A70EQ52934731-7A9E1D7B-878D-4F06-A0F8-8082E9853FFFQ53342879-8758E2FC-0C62-4C57-8D34-93514AA8E03DQ55314389-B0D4EDAD-9080-41B8-AE78-C7B62A4C5B46Q58127469-4A79A4B1-8603-4E33-B953-B0D9321B365F
P2860
Reduced Klotho is associated with the presence and severity of coronary artery disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Reduced Klotho is associated with the presence and severity of coronary artery disease.
@en
Reduced Klotho is associated with the presence and severity of coronary artery disease.
@nl
type
label
Reduced Klotho is associated with the presence and severity of coronary artery disease.
@en
Reduced Klotho is associated with the presence and severity of coronary artery disease.
@nl
prefLabel
Reduced Klotho is associated with the presence and severity of coronary artery disease.
@en
Reduced Klotho is associated with the presence and severity of coronary artery disease.
@nl
P2093
P2860
P50
P1433
P1476
Reduced Klotho is associated with the presence and severity of coronary artery disease
@en
P2093
Horacio Pérez-Hernández
Mercedes Muros de Fuentes
Rafael Martínez-Sanz
P2860
P356
10.1136/HEARTJNL-2013-304746
P407
P577
2013-10-28T00:00:00Z